Morocco medication price cuts impact
The pharmaceutical pricing policy in Morocco sparks debate between efforts to ease the financial burden on citizens, especially those with limited income, and fears that lowering prices may lead to medicine shortages and halt the production of some drugs, particularly those with low prices. Experts emphasize that the focus should be on reducing the prices of high-cost medicines, such as imported drugs, while ensuring the continued availability of low-cost medicines, as the market faces shortages of certain items due to unprofitability in their production. The government has indicated that it is working to review the drug pricing system with the goal of reducing costs and improving access to medicines for citizens, while maintaining the sustainability of pharmacies and balancing policies to serve both patient interests and the health sector. Currently, pharmacies are experiencing financial difficulties, and the consequences of price reductions could lead to the closure of some, especially given the rising costs of chronic disease medications, missing medicines, or those imported from abroad at high prices.
Notice: This Is an AI-Generated Summary
Comments (0)